Company Monitoring Page for Bayer

latest headlines for company on cafepharma

Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
Tags:
drug launches, Eylea, Regeneron, Bayer, Tecfidera, Biogen Idec, Kalydeco, Vertex Pharmaceuticals, Kadcyla, Roche, Genentech, Victoza, Novo Nordisk, Gilenya, Novartis, Zytiga, JNJ, Yervoy, Bristol-Myers Squibb, Stribild, Gilead Sciences Xtandi, Medivation, Astellas, Afinitor, Amgen, Prolia, Stelara, Kyprolis, Xarelto, ONYX Pharmaceuticals
Bayer Chastised For Nightcaps After A Medical Conference
Pharmalot
Mon, 09/30/13 - 10:35 am
Tags:
Bayer
Bayer appoints Pfizer's Brandicourt as head of healthcare
Yahoo/Reuters
Mon, 09/30/13 - 10:32 am
Tags:
Bayer, Pfizer
FDA grants two orphan drug designations for Bayer's Riociguat
Pharmaceutical Business Review
Fri, 09/27/13 - 08:30 am
Tags:
FDA, orphan drugs, Bayer, Riociguat
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Tags:
Europe, drug approvals, Kadcyla, Roche, Bayer, Xofigo, Abilify Maintena, Otsuka, Lundbeck, Memantine Accord, Accord Healthcare, Levodopa Carbidopa Entacapone Sandoz, Orion, Vitekta, Gilead, Janssen-Cilag, Invokana, Novo Nordisk, NovoEight, AstraZeneca, Fluenz Tetra, GSK, Relvar Ellipta, Lidocaine/Prilocaine Plethora, Plethora Solutions
Aging population to fuel big leap in cancer cases--and drug sales
Fierce Pharma
Tue, 09/17/13 - 12:36 pm
Tags:
cancer, aging, Roche, Celgene, GSK, Novartis, Pfizer, Bayer
Is Seattle Genetics an Acquisition Target?
Motley Fool
Tue, 09/10/13 - 10:26 am
Tags:
M&A, Seattle Genetics, Adcetris, Bayer, AbbVie, Genentech
Bayer's Xarelto faces stepped-up reports of side effects, deaths
Fierce Pharma
Mon, 09/9/13 - 10:26 am
Tags:
Bayer, Xarelto, bloodthinners
Bayer's Nexavar gets priority review as thyroid cancer drug
Reuters
Tue, 08/27/13 - 09:31 am
Tags:
Bayer, Nexavar, thyroid cancer
These drugs are the cash cows of big pharma
Quartz
Tue, 08/20/13 - 12:20 pm
Tags:
JNJ, Novartis, Pfizer, Merck, Roche, Bayer, Sanofi, GSK, Abbott Labs, AstraZeneca, Eli Lilly
Bayer Reports $1.4 Billion in Yaz and Yasmin Settlements
Injury Lawyer News
Fri, 08/16/13 - 10:54 am
Tags:
Bayer, Yaz, Yasmin, settlements
How Much To Develop A Drug? An Update
Seeking Alpha
Mon, 08/12/13 - 11:51 am
Tags:
R&D, AstraZeneca, Bayer, Eli Lilly, Novartis, Pfizer, Regeneron, Roche, Shire, Takeda
This Week in Biotech
Motley Fool
Sun, 08/11/13 - 10:57 am
Tags:
Celgene, CompuGen, Bayer, Isis Pharmaceuticals, Onyx, Novo Nordisk, Amgen
Multiple Parties Involved in Potential Onyx Sale, CEO Says
Bloomberg
Thu, 08/8/13 - 06:52 pm
Tags:
ONYX Pharmaceuticals, M&A, Amgen, Bayer
A House Bill Would Change Exclusivity For Some Combo Drugs
Pharmalot
Tue, 08/6/13 - 11:12 am
Tags:
Gilead, FDA, Bayer, Ferring
Bayer enters cancer research deal with Compugen
Reuters
Mon, 08/5/13 - 09:43 am
Tags:
Bayer, CompuGen, antibodies
Bayer Lung Drug Should Be Approved at Low Dose, FDA Says
Bloomberg
Fri, 08/2/13 - 10:53 am
Tags:
Bayer, FDA, drug approvals, pulmonary hypertension, Riociguat
Who Could Buy Onyx and at What Price?
Motley Fool
Sun, 07/14/13 - 11:21 am
Tags:
Onyx, M&A, Amgen, Bayer, Celgene
China's Coming Big Pharma Boom
Motley Fool
Wed, 07/10/13 - 11:07 am
Tags:
China, Big Pharma, Merck, Novo Nordisk, Bayer, Pfizer, Teva
Who Is the Best Suitor for Onyx?
Motley Fool
Tue, 07/9/13 - 08:03 am
Tags:
M&A, ONYX Pharmaceuticals, Bayer, Amgen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.